Difference between revisions of "Week4"
Line 4: | Line 4: | ||
*Title | *Title | ||
− | |||
− | |||
*Reference | *Reference | ||
Line 33: | Line 31: | ||
*Title | *Title | ||
+ | |||
+ | Longitudinal Modeling of Age-Related Memory Decline and the APOE epsilon4 Effect | ||
+ | |||
*Reference | *Reference | ||
+ | |||
+ | Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM. N Engl J Med. 2009 Jul 16;361(3):255-63. | ||
+ | |||
*Abstract | *Abstract | ||
Line 60: | Line 64: | ||
*Introduction/Aims | *Introduction/Aims | ||
+ | |||
+ | The epsilon4 allele of apolipoprotein E (APOE4) is the most prevalent genetic risk factor for sporadic Alzheimer's disease identified to date. | ||
*Methods | *Methods |
Revision as of 18:39, 13 January 2010
Back to NS210b Class page
Contents
MANUSCRIPT ID
- Title
- Reference
- Abstract
- Keywords
- Input Author
MANUSCRIPT DETAILS
- Introduction/Aims
- Methods
- Results
- Summary
- Discussion
MANUSCRIPT ID
- Title
Longitudinal Modeling of Age-Related Memory Decline and the APOE epsilon4 Effect
- Reference
Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM. N Engl J Med. 2009 Jul 16;361(3):255-63.
- Abstract
Background: The APOEepsilon4 allele is associated with the risk of late-onset Alzheimer's disease. The age at which memory decline diverges among persons who are homozygous for the APOEepsilon4 allele, those who are heterozygous for the allele, and noncarriers is unknown.
Methods: Using local advertisements, we recruited cognitively normal subjects between the ages of 21 and 97 years, who were grouped according to their APOEepsilon4 status. We then followed the subjects with longitudinal neuropsychological testing. Anyone in whom mild cognitive impairment or dementia developed during follow-up was excluded. We compared the rates of decline in predetermined cognitive measures between carriers and noncarriers of the APOEepsilon4 allele, using a mixed model for longitudinal change with age.
Results: We analyzed 815 subjects: 317 APOEepsilon4 carriers (79 who were homozygous for the APOEepsilon4 allele and 238 who were heterozygous) and 498 noncarriers. Carriers, as compared with noncarriers, were generally younger (mean age, 58.0 vs. 61.4 years; P<0.001) and were followed for a longer period (5.3 vs. 4.7 years, P=0.01), with an equivalent duration of formal education (15.4 years) and proportion of women (69%). Longitudinal decline in memory in carriers began before the age of 60 years and showed greater acceleration than in noncarriers (P=0.03), with a possible allele–dose effect (P=0.008). We observed similar although weaker effects on measures of visuospatial awareness and general mental status.
Conclusions: Age-related memory decline in APOEepsilon4 carriers diverges from that of noncarriers before the age of 60 years, despite ongoing normal clinical status.
- Keywords
memory decline, APOE4, memory disorders, longitudinal neuropsychological testing
- Input Author
Kelley O'Donnell
MANUSCRIPT DETAILS
- Introduction/Aims
The epsilon4 allele of apolipoprotein E (APOE4) is the most prevalent genetic risk factor for sporadic Alzheimer's disease identified to date.
- Methods
- Results
- Summary
- Discussion
INFORMATICS: GenBank
GenBank is an open-access database of annotated sequences of DNA, mRNA, and the corresponding proteins. One can add [1] to the database, submitting sequences, further annotations, and corrections. Alternatively (and likely more usefully), one can search GenBank. Searches are conducted via Entrez Nucleotide [2].